Table 4.

Univariate analysis to identify potential predictors of graft loss.

DBD
	Univariate analysis
Parameter	HR	95% CI	p value
Recipient age	1.006	0.994-1.018	0.302
Recipient gender	1.256	0.916-1-721	0.157
Donor age	1.021	1.012-1.030	<0.001
Donor gender	0.722	0.538-0.970	0.031
Cold ischemia time	0.991	0.957-1-026	0.591
DSA	1.408	1.011-1.961	0.043
DSA class
No DSA	Reference
DSA I	0.622	0.291-1.331	0.221
DSA II	1.517	0.981-2.348	0.061
DSA I+II	2.427	1.463-4.025	<0.001
Induction therapy
ATG/Thymo	1.328	0.964-1.829	0.083
Basiliximab	0.797	0.581-1.095	0.161
Rejections
ABMR	3.311	2.353-4.659	<0.001
TCMR	2.019	1.473-2.768	<0.001
DCD
	Univariate analysis
Parameter	HR	95% CI	p value
Recipient age	0.98	0.937-1.024	0.367
Recipient gender	3.205	0.677-15.170	0.142
Donor age	1.03	0.979-1.084	0.26
Donor gender	1.644	0.424-6.371	0.472
Cold ischemia time	1.136	0.953-1.355	0.154
DSA	3.027	0.854-10.730	0.086
DSA class
No DSA	/
DSA I	/
DSA II	/
DSA I+II	/
Induction therapy
ATG/Thymo	3.272	0.414-25.880	0.261
Basiliximab	0.317	0.040-2.509	0.277
Rejections
ABMR	6.679	0.841-53.050	0.073
TCMR	5.963	1.528-23.270	0.01
Living related
	Univariate analysis
Parameter	HR	95% CI	p value
Recipient age	1.002	0.983-1.021	0.835
Recipient gender	0.765	0.444-1.317	0.334
Donor age	1.026	1.000-1.052	0.054
Donor gender	1.323	0.772-2.270	0.309
Cold ischemia time	1.045	1.006-1.085	0.023
DSA	2.251	1.204-4.209	0.011
DSA class
No DSA	Reference
DSA I	1.325	0.410-4.283	0.638
DSA II	2.851	1.335-6.097	0.007
DSA I+II	2.854	0.687-11.855	0.149
Induction therapy
ATG/Thymo	1.332	0.701-2.530	0.381
Basiliximab	0.935	0.500-1.747	0.832
Rejections
ABMR	3.174	1.635-6.161	<0.001
TCMR	2.427	1.385-4.256	0.002

HR, Hazard ratio; CI, confidence interval.

Bold values indicate significance.